SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-010973
Filing Date
2014-01-14
Accepted
2014-01-14 17:27:55
Documents
6
Period of Report
2014-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d658291d8k.htm 8-K 15331
2 EX-99.1 d658291dex991.htm EX-99.1 17062
3 GRAPHIC g658291img001.jpg GRAPHIC 138729
4 GRAPHIC g658291img002.jpg GRAPHIC 607532
5 GRAPHIC g658291img012.jpg GRAPHIC 131713
6 GRAPHIC g658291img019.jpg GRAPHIC 129820
  Complete submission text file 0001193125-14-010973.txt   1422765
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 14528138
SIC: 2834 Pharmaceutical Preparations